Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

DelSiTech: leveraging silica’s properties to improve drug delivery

Finland-based drug delivery company DelSiTech recently secured funding from the Bill and Melinda Gates Foundation to assist the development of thermostablised vaccines using its Silica Matrix technology. The technology could enable vaccines to be stored at room temperature or 4°C, allowing lifesaving medicines to stay effective for far longer, as Allie Nawrat finds out.

Download our 2018 Technology, Media & Telecoms Predictions worth over $5,000 for free

Close
Close
Close

Go Top